Effect of Mouthrinsing on Inflammation of the Gums.
Effect of an Amine Fluoride/Stannous Fluoride Containing Mouthrinse on Gingival Inflammation,Plaque Development, Discoloration and Bacterial Plaque Composition Over Six Months.
1 other identifier
interventional
180
1 country
1
Brief Summary
The purpose of this study is to determine whether rinsing with an amine fluoride/stannous flouride mouthrinse in addition to daily tooth brushing is more effective than tooth brushing alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Nov 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 16, 2011
CompletedFirst Posted
Study publicly available on registry
March 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJanuary 18, 2012
January 1, 2012
1.2 years
March 16, 2011
January 16, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in gingivitis
To proof whether rinsing with ASF adjunctive to mechanical oral hygiene is more effective on gingivitis reduction than mechanical oral hygiene alone.
6 months
Secondary Outcomes (4)
Reduction in plaque
6 months
Discoloration of teeth
6 months
Bacterial colonization
6 months
Adverse events
6 months
Study Arms (2)
amine fluoride/stannous fluoride
EXPERIMENTALAmine fluoride/stannous fluoride mouthrinse in addition to mechanical oral hygiene
No rinsing
NO INTERVENTIONMechanical oral hygiene only
Interventions
10 ml qd, oral, topical, 6 months duration
Eligibility Criteria
You may qualify if:
- Healthy male and female adults aged ≥18 years.
- Participants who have gingivitis/mild chronic periodontitis (approximal probing depth ≤ 3.5 mm at ≥ 80 % of the sites and at ≤ 20 % of the sites \> 3.5 mm and \< 5 mm).
- Participants must have read, understood and signed the informed consent form.
- Participants who have a GI ≥ 1.3 at baseline.
- Participants who have at least 20 own teeth excluding the wisdom teeth (incl. 16 natural crowns).
- Participants who have an acceptable compliance according to the investigators' assessment.
You may not qualify if:
- Participants who have systemic diseases that require regular systemic medication intake that may affect the gingival condition (e. g. phenytoin, nifedipine, cyclosporine, antibiotics, steroids, antiphlogistics).
- Participants who require antibiotic treatments for dental appointments (endocarditis prophylaxis).
- Participants who were treated with antibiotics 8 weeks before recruitment and during the course of the study.
- Participants who were treated with any antibacterial mouthrinse 6 weeks before recruitment.
- Participants who use other than the recommended mouthrinse or toothpaste during the study period.
- Participants who have moderate and severe chronic or aggressive periodontitis.
- Participants who have irregularities of the gingival tissues, e. g. hyperplastic gingiva, mucosal diseases.
- Participants who have rampant caries.
- Participants under guardianship or without freedom by administrative or legal award.
- Known hypersensitivity or allergy to the study product and standard toothpaste ingredients used in the present study.
- Known pregnancy or breast feeding during the course of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Technische Universität Dresdenlead
- Gaba International AGcollaborator
Study Sites (1)
Dreden University of Technology, Universitätsklinikum, Poliklinik für Parodontologie
Dresden, Saxony, 01109, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Hoffmann, Prof. Dr.
Technische Universität Dresden
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2011
First Posted
March 17, 2011
Study Start
November 1, 2010
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
January 18, 2012
Record last verified: 2012-01